97 related articles for article (PubMed ID: 1641819)
1. Experimental carotid stenosis and endothelial injury in the rabbit: an in vivo model to study intravascular platelet aggregation.
Golino P; Ambrosio G; Pascucci I; Ragni M; Russolillo E; Chiariello M
Thromb Haemost; 1992 Mar; 67(3):302-5. PubMed ID: 1641819
[TBL] [Abstract][Full Text] [Related]
2. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation.
Golino P; Cappelli-Bigazzi M; Ambrosio G; Ragni M; Russolillo E; Condorelli M; Chiariello M
Circ Res; 1992 Dec; 71(6):1447-56. PubMed ID: 1423938
[TBL] [Abstract][Full Text] [Related]
5. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
[TBL] [Abstract][Full Text] [Related]
6. Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury.
Ragni M; Golino P; Cirillo P; Scognamiglio A; Piro O; Esposito N; Battaglia C; Botticella F; Ponticelli P; Ramunno L; Chiariello M
Circulation; 2000 Jul; 102(1):113-7. PubMed ID: 10880423
[TBL] [Abstract][Full Text] [Related]
7. An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis.
Folts J
Circulation; 1991 Jun; 83(6 Suppl):IV3-14. PubMed ID: 2040070
[TBL] [Abstract][Full Text] [Related]
8. Short-term and long-term role of platelet activating factor as a mediator of in vivo platelet aggregation.
Golino P; Ambrosio G; Ragni M; Pascucci I; Triggiani M; Oriente A; McNatt J; Buja LM; Condorelli M; Chiariello M
Circulation; 1993 Sep; 88(3):1205-14. PubMed ID: 8353882
[TBL] [Abstract][Full Text] [Related]
9. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo.
De Clerck F; Beetens J; Van de Water A; Vercammen E; Janssen PA
Thromb Haemost; 1989 Feb; 61(1):43-9. PubMed ID: 2526385
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.
Ogletree ML; Harris DN; Heran CL; Phillips MB; Michel IM; Goldenberg HJ
Eicosanoids; 1988; 1(2):85-91. PubMed ID: 2856188
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
[TBL] [Abstract][Full Text] [Related]
13. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
[TBL] [Abstract][Full Text] [Related]
14. LY53857, a 5HT2 receptor antagonist, delays occlusion and inhibits platelet aggregation in a rabbit model of carotid artery occlusion.
Wilson HC; Coffman W; Killam AL; Cohen ML
Thromb Haemost; 1991 Sep; 66(3):355-60. PubMed ID: 1746008
[TBL] [Abstract][Full Text] [Related]
15. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.
Valentin JP; Vieu S; Bertolino F; Fauré P; John GW
J Pharmacol Exp Ther; 1997 Feb; 280(2):761-9. PubMed ID: 9023289
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
Rübsamen K; Hornberger W; Kirchengast M
Thromb Haemost; 1995 Nov; 74(5):1353-60. PubMed ID: 8607122
[TBL] [Abstract][Full Text] [Related]
18. Aurintricarboxylic acid reduces platelet deposition in stenosed and endothelially injured rabbit carotid arteries more effectively than other antiplatelet interventions.
Golino P; Ragni M; Cirillo P; Pascucci I; Ezekowitz MD; Pawashe A; Scognamiglio A; Pace L; Guarino A; Chiariello M
Thromb Haemost; 1995 Sep; 74(3):974-9. PubMed ID: 8571332
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Le Breton GC; Lipowski JP; Feinberg H; Venton DL; Ho T; Wu KK
J Pharmacol Exp Ther; 1984 Apr; 229(1):80-4. PubMed ID: 6423815
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
